Is Maitri Enterprises a good stock to invest in?

Maitri Enterprises can be analyzed on the following key metrics - TTM P/E: 41.54 Sector P/E: 0 Dividend Yield: 0% D/E ratio: -

Maitri Enterprises Share Price

Sector: Major Drugs

Powered by

35.85 -0.32 (-0.88%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 35.85

Today’s High 36.17

52 Week Low 18.71

52 Week High 51.34

Key Metrics

Market Cap (In Cr) 15.77
Beta 0.08
Div. Yield (%) 0
P/B 3.36
TTM P/E 41.54
Sector P/E 0
D/E 0.01
Open Price 36.17
Prev Close 36.17

View All Metrics

Maitri Enterprises Analysis

Price Analysis

1 Week

13.59%
3 Months

36.99%
6 Month

40.59%
YTD

37.88%
1 Year

34.32%

Risk Meter

55% Low risk
55% Moderate risk
55% Balanced Risk
55% High risk
55% Extreme risk

Maitri Enterprises Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
28.66

Selling/ General/ Admin Expenses Total
1.77

Depreciation/ Amortization
0.07

Other Operating Expenses Total
5.43

Total Operating Expense
27.61

Operating Income
1.05

Net Income Before Taxes
0.33

Net Income
0.17

Diluted Normalized EPS
0.38

Period
2024

Total Revenue
19.01

Selling/ General/ Admin Expenses Total
1.3

Depreciation/ Amortization
0.06

Other Operating Expenses Total
1.63

Total Operating Expense
18.83

Operating Income
0.19

Net Income Before Taxes
-0.42

Net Income
-0.45

Diluted Normalized EPS
-1.02

Period
2023

Total Revenue
13.33

Selling/ General/ Admin Expenses Total
1.19

Depreciation/ Amortization
0.07

Other Operating Expenses Total
0.51

Total Operating Expense
12.9

Operating Income
0.42

Net Income Before Taxes
0.17

Net Income
0

Diluted Normalized EPS
0

Period
2022

Total Revenue
20.09

Selling/ General/ Admin Expenses Total
1.06

Depreciation/ Amortization
0.09

Other Operating Expenses Total
0.89

Total Operating Expense
19.49

Operating Income
0.6

Net Income Before Taxes
0.34

Net Income
0.23

Diluted Normalized EPS
0.84

Period
2021

Total Revenue
4.55

Selling/ General/ Admin Expenses Total
0.54

Depreciation/ Amortization
0.05

Other Operating Expenses Total
0.23

Total Operating Expense
4.5

Operating Income
0.05

Net Income Before Taxes
0.11

Net Income
0.07

Diluted Normalized EPS
0.38

Period
2020

Total Revenue
6.34

Selling/ General/ Admin Expenses Total
0.36

Depreciation/ Amortization
0.04

Other Operating Expenses Total
-0.16

Total Operating Expense
6.39

Operating Income
-0.05

Net Income Before Taxes
0.21

Net Income
0.16

Diluted Normalized EPS
0.86

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Maitri Enterprises Technical

Moving Average SMA

5 Day34.22
10 Day30.78
20 Day27.38

50 Day28.89
100 Day32.94
300 Day33.31

Maitri Enterprises Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Zenlabs Ethica
33.2
-0.75
-2.21
52.1
27.33
21.61

Muller And Phipps India
346
4.35
1.27
726.2
215.75
21.58

Maitri Enterprises
35.85
-0.32
-0.88
51.34
18.71
15.77

Checkpoint Trends
26.39
0.51
1.97
28.88
6.08
14.43

Patron Exim
6
-0.1
-1.64
9.8
4.8
13.91

Maitri Enterprises Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

30-May-25
Audited Results

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

14-Aug-24
Quarterly Results

30-May-24
Audited Results

28-May-24
Audited Results

14-Feb-24
Quarterly Results

10-Nov-23
Quarterly Results

12-Aug-23
Quarterly Results

30-May-23
Audited Results

Meeting Date
Announced on
Purpose

28-Sept-24
06-Sept-24
AGM

28-Sept-23
17-Aug-23
AGM

View All

Company Profile

ABOUT Maitri Enterprises

Industry Major Drugs
ISIN INE501L01024
BSE Code 513430

Maitri Enterprises Limited is an India-based company. The Company is primarily engaged on pharmaceutical business, construction and developmental activities in the real-estate market along with trading metal furniture and building materials. The Company is dedicated to expanding its product portfolio. Its segments include Pharmaceutical Goods, and Sale of service by way of works contract. The distribution network of the Company is in Ahmedabad region.

MANAGEMENT

Alpeshkumar Patel Chief Financial Officer
Jaikishan Ambwani Managing Director, Executive Director

MAITRI ENTERPRISES SUMMARY

Maitri Enterprises is trading 0.88% lower at Rs 35.85 as compared to its last closing price. Maitri Enterprises has been trading in the price range of 36.17 & 35.85. Maitri Enterprises has given 37.88% in this year & 13.59% in the last 5 days.

Maitri Enterprises has TTM P/E ratio 41.54.

The company posted a net profit of -0.02 Crores in its last quarter.

Listed peers of Maitri Enterprises include Zenlabs Ethica (-2.21%), Muller And Phipps India (1.27%), Maitri Enterprises (-0.88%) etc.

Maitri Enterprises has a 63.01% promoter holding & 36.99% public holding.

FAQs about Maitri Enterprises

Maitri Enterprises is trading at 35.85 as on 27 Jun, 2025 3:15:00 PM. This is -0.88% lower as compared to its previous closing price of 36.17

The market capitalization of Maitri Enterprises is 15.77 Cr as on 27 Jun, 2025 3:15:00 PM.

The 52 wk high for Maitri Enterprises is 51.34 whereas the 52 wk low is 18.71

Maitri Enterprises can be analyzed on the following key metrics -

TTM P/E: 41.54
Sector P/E: 0
Dividend Yield: 0%
D/E ratio: -

Maitri Enterprises reported a net profit of 0.17 Cr in 2025.

Maitri Enterprises Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Maitri Enterprises Share Price

Price Range

Key Metrics

Maitri Enterprises Analysis

Maitri Enterprises Financials

Forecast

Forecast

Forecast

Maitri Enterprises Technical

Maitri Enterprises Peers

Maitri Enterprises Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Maitri Enterprises

MANAGEMENT

MAITRI ENTERPRISES SUMMARY

FAQs about Maitri Enterprises

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue